Skip to main content

Signal-Averaged ECG Upgrade For Existing MAC VU360™ Resting ECG Machine - ECG Equipment

Reference: 1628
Type: Capital Savings
Start Date: 5 November 2026
Expiry Date: 31 March 2027

Save 10% on framework price of the GE HealthCare Signal-Averaged ECG upgrade for existing MAC VU360™ Resting ECG machine and receive a free HEIM lead wires.

Signal-averaged electrocardiography (SAECG) is an upgrade for existing MAC VU360™ ECG machines that adds advanced cardiac risk assessment to a system already in place. Used in the cardiology arena, SAECG detects subtle, low-amplitude, high-frequency electrical signals known as late potentials, which occur at the end of the Ventricular Depolarisation (QRS) complex and are typically too small to be seen on a standard ECG.

It works by acquiring hundreds of QRS complexes, aligning them precisely and averaging them, revealing conduction abnormalities associated with scarred or diseased heart tissue. This supports early risk stratification for life-threatening arrhythmias, particularly ventricular tachycardia, and is most valuable for post-myocardial-infarction patients, patients with inherited cardiac conditions, such as arrhythmogenic right ventricular dysplasia or cardiomyopathy, and for therapy monitoring.

Signal-averaged electrocardiography is addressed in guidance from the European Society of Cardiology, the American Heart Association and the American College of Cardiology, and in published technical standards. Delivered as a software upgrade, it needs no installation downtime.

Features and Benefits

  • Upgrade to existing MAC VU360™ ECG machines, with no new hardware installation required.
  • Detects late potentials: low-amplitude, high-frequency signals not visible on a standard ECG.
  • Acquires, precisely aligns and averages hundreds of QRS complexes to reveal hidden abnormalities.
  • Supports early risk stratification for life-threatening arrhythmias, particularly ventricular tachycardia.
  • Identifies conduction abnormalities linked to scarred or diseased heart tissue.
  • Most valuable for post-myocardial-infarction and inherited cardiac conditions, and for therapy monitoring.
  • Addressed in European Society of Cardiology and American Heart Association guidance.
  • A set of HEIM lead wires is included with the upgrade during the promotional period.
  • Clinical View educational resources available to GE HealthCare users.

This offer is over and above the standard discount available through the NHS Supply Chain framework agreement. The discount is a fixed term offer. All orders must be placed before 31 March 2027.

For more information, please contact

Connor Shaw

Category Buyer

connor.shaw@supplychain.nhs.uk

0115 678 6671

GE HealthCare Signal-Averaged ECG Upgrade For Existing MAC VU360™ Resting ECG Machine
GE Healthcare Logo